AddoloratoGCaputoFCapristoE. (2000) Ability of baclofen in reducing alcohol craving and intake: II—Preliminary clinical evidence. Alcohol Clin Exp Res24: 67–71.
2.
AddoloratoGLeggioLFerrulliA. for the Baclofen Study Group (2011) Dose–response effect of baclofen in reducing daily alcohol intake in alcohol dependence: secondary analysis of a randomized, double-blind, placebo-controlled trial. Alcohol Alcohol46: 312–317.
3.
AgabioRMarrasPAddoloratoG. (2007) Baclofen suppresses alcohol intake and craving for alcohol in a schizophrenic alcohol-dependent patient: a case report. J Clin Psychopharmacol27: 319–320.
4.
AmeisenO (2005a) Complete and prolonged suppression of symptoms and consequences of alcohol-dependence using high-dose baclofen: a self-case report of a physician. Alcohol Alcohol40: 147–150.
AmeisenO (2011) High-dose baclofen for suppression of alcohol dependence. Alcohol Clin Exp Res2011; 35: 845–846; author reply 847.
7.
BottlenderMSoykaM. (2004) Impact of craving on alcohol relapse during, and 12 months following, outpatient treatment. Alcohol Alcohol39: 357–361.
8.
BucknamW (2007) Suppression of symptoms of alcohol dependence and craving using high-dose baclofen. Alcohol Alcohol42: 158–160.
9.
CaputoFAddoloratoGStoppoM. (2007) Comparing and combining gamma-hydroxybutyric acid (GHB) and naltrexone in maintaining abstinence from alcohol: an open randomised comparative study. Eur Neuropsychopharmacol17: 781–789.
10.
ChickJNuttD (2011) Substitution therapy for alcoholism: time for a reappraisal?J Psychopharmacol26: 205–212.
11.
HeinzABeckAMirJ. (2010) Alcohol craving and relapse prediction: imaging studies. In: KuhnCMKoobGF (eds), Advances in the Neuroscience of Addiction, 2nd edn.Boca Raton, FL: CRC Press.
12.
WebsterLRCochellaSDasguptaN. (2011) An analysis of the root causes for opioid-related overdose deaths in the United States. Pain Med (12Suppl. 2): S26–S35.
